Review summary
Teaching objective: Treat a recurrent, moderately severe episode of major depressive disorder in a 52-year-old nurse and relief-agency leader after a prolonged wartime deployment, following the 2022 VA/DoD guideline and the CMID depression monograph: shared decision-making for combined psychotherapy and an SSRI, a two-week tolerability and safety check, PHQ-9 at least monthly to response and remission, dose titration for partial response, suicide-risk review with a safety plan and the 988 Lifeline at every visit, sleep, burnout, and a phased return to work, social support, and continuation treatment after remission, while explaining that prolonged rest is not a treatment for depression.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| December 25, 1821 | Born in North Oxford, Massachusetts. | CLM-0001 |
| Spring 1852 | Brief period of depression recorded in her diary while teaching. | CLM-0002 |
| September 1862 | Tends the wounded at Antietam and is weakened afterward by typhoid fever. | CLM-0003, CLM-0004 |
| March 1865 | Opens the office that searches for missing soldiers, which runs to 1869. | CLM-0005 |
| December 1868 | Loses her voice during a lecture from fatigue and mental prostration. | CLM-0006 |
| September 1869 | Travels to Europe on medical advice to regain her health. | CLM-0007 |
| 1870 to 1871 | Organizes civilian relief during the Franco-Prussian War. | CLM-0008 |
| October 1872 | Breaks down with a cough in England and is confined to bed for eight months. | CLM-0009 |
| October 1873 | Returns home and breaks down with prostration of the nervous system. | CLM-0010 |
| 1876 | Moves to Dansville, New York, and gradually regains her strength. | CLM-0011 |
| May 21, 1881 | The American Association of the Red Cross is formed, with her as president. | CLM-0014 |
| May 14, 1904 | Resigns as president of the American National Red Cross. | CLM-0014 |
| April 12, 1912 | Dies at her Glen Echo home at 90. | CLM-0015 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Clarissa Harlowe Barton was born on December 25, 1821, in North Oxford, Massachusetts, the youngest of five children. | confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 1. Boston: Houghton Mifflin; 1922 supports |
| D | Her diary records a brief period of depression in the spring of 1852, while she was teaching in New Jersey; her biographer judged that the mood did not last long. Her own diary entries, quoted by her biographer. |
confirmed | Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 1. Boston: Houghton Mifflin; 1922 supports |
| D | From 1861 she supplied and tended wounded soldiers at battlefields and field hospitals through the Civil War; after working for several days following the Battle of Antietam in September 1862 she was weakened by typhoid fever. | confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports |
| D | In her account of the eve of the Battle of Antietam she wrote that she was faint but could not eat, weary but could not sleep, and depressed but could not weep. Her own words, quoted by her biographer. |
confirmed | Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 1. Boston: Houghton Mifflin; 1922 supports |
| D | From March 1865 to 1869 she ran an office that answered 63,182 letters and identified 22,000 missing soldiers. | confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports |
| D | In December 1868 she lost her voice while giving a lecture, from fatigue and mental prostration; in her own later account, nervous prostration had declared itself and she lay helpless all winter in Washington. Nervous prostration is a nineteenth-century term, not a modern diagnosis. |
confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 2. Boston: Houghton Mifflin; 1922 supports |
| D | In September 1869, on her doctor's advice, she travelled to Europe to regain her health. | confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 2. Boston: Houghton Mifflin; 1922 supports |
| D | During the Franco-Prussian War of 1870 and 1871 she organized civilian relief in Strasbourg, Paris, and other French cities. | confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports |
| D | In 1872 and 1873 she suffered nervous exhaustion and temporarily lost her eyesight; in a letter she wrote that she broke down with a cough in England in October 1872 and was confined to bed for eight months. | confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 2. Boston: Houghton Mifflin; 1922 supports |
| D | After her return in October 1873 she broke down again with what she called prostration of the nervous system, deepened by her only sister's death in May 1874; she wrote that for almost a year she averaged less than two hours of sleep a day and could not write her name for over four months. Her own account in letters quoted by her biographer. |
confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 2. Boston: Houghton Mifflin; 1922 supports |
| D | In 1876 she moved to Dansville, New York, first living at a sanitarium that she called the largest and most noted water and rest cure in the country and later in her own home; she regained her strength gradually over several years, with periods of depression and weakness. Historical treatment. Her recovery cannot be credited to the rest cure, and rest cures are not an effective treatment for depression. |
confirmed | Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 2. Boston: Houghton Mifflin; 1922 supports Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports |
| R | A 1995 review by Spiegel describes her long-term nervous prostration and argues that the therapy she received changed her behavioral approach to illness and to life. A retrospective interpretation. |
possible | Spiegel AD. The role of gender, phrenology, discrimination and nervous prostration in Clara Barton's career. J Community Health. 1995;20(6):501-526. doi:10.1007/BF02277066 supports |
| R | Her biographer Elizabeth Brown Pryor, as quoted in a 2012 newspaper article, describes a long struggle with depression that was lifted by a need for her services. A retrospective interpretation of her diaries; no diagnosis was made in her lifetime. |
possible | Henneberger M. Clara Barton's inner war. Bangor Daily News, April 7, 2012 supports |
| D | The American Association of the Red Cross was formed on May 21, 1881, with her as president; she resigned the presidency on May 14, 1904. | confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports |
| D | She died at her home in Glen Echo, Maryland, on April 12, 1912, aged 90, during a second illness with double pneumonia; she had recovered from an earlier attack the winter before. | confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 2. Boston: Houghton Mifflin; 1922 supports |
| D | Her mother died on July 18, 1851, and her father on March 21, 1862. Causes are not recorded in the cited source. |
confirmed | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Major depressive disorder, recurrent, moderate (moderately severe symptoms at intake), after a prolonged humanitarian deployment; synthetic modern diagnosis linked to her documented periods of depression and nervous prostration | active | confirmed | both_with_link | CLM-0002, CLM-0006, CLM-0010, CLM-0013 |
| S | Occupational burnout after eighteen months leading field medical relief in a war zone | active | confirmed | both_with_link | CLM-0008, CLM-0009 |
| S | Acute low back strain after lifting supply crates, without red flags or radicular signs; resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-01-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 18 | http://loinc.org · 44261-6 |
| S | 2026-01-20 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | http://loinc.org · 70274-6 |
| S | 2026-01-20 | PC-PTSD-5 score [PC-PTSD-5] | 2 | http://loinc.org · 102017-1 |
| S | 2026-01-20 | Total score [AUDIT-C] | 2 | http://loinc.org · 75626-2 |
| S | 2026-01-20 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-01-20 | Potassium [Moles/volume] in Serum or Plasma | 4.2 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-01-20 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 2026-01-20 | Urea nitrogen [Mass/volume] in Serum or Plasma | 14 mg/dL Reference 6-21 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-01-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.78 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-01-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 91 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-01-20 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-01-20 | Hemoglobin [Mass/volume] in Blood | 13.1 g/dL Reference 12-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-01-20 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 mIU/L Reference 0.4-4 mIU/L |
http://loinc.org · 3016-3 |
| S | 2026-01-20 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 486 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 2026-02-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 16 | http://loinc.org · 44261-6 |
| S | 2026-03-03 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 12 | http://loinc.org · 44261-6 |
| S | 2026-04-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | http://loinc.org · 44261-6 |
| S | 2026-04-14 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 4 | http://loinc.org · 70274-6 |
| S | 2026-06-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | http://loinc.org · 44261-6 |
| S | 2026-10-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 2026-10-13 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | http://loinc.org · 70274-6 |
| S | 2026-10-13 | Total score [AUDIT-C] | 1 | http://loinc.org · 75626-2 |
| S | 2026-10-13 | Cholesterol [Mass/volume] in Serum or Plasma | 196 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-10-13 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 64 mg/dL Reference >=50 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-10-13 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-10-13 | Triglyceride [Mass/volume] in Serum or Plasma | 98 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-10-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4% Reference <=5.6% |
http://loinc.org · 4548-4 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-01-20 | Body height | 152 cm | 8302-2 | S |
| 2026-01-20 | Body weight | 49.8 kg | 29463-7 | S |
| 2026-01-20 | Body mass index (BMI) [Ratio] | 21.6 kg/m2 | 39156-5 | S |
| 2026-01-20 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-01-20 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-01-20 | Heart rate | 82 /min | 8867-4 | S |
| 2026-01-20 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-01-20 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-01-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-02-03 | Body height | 152 cm | 8302-2 | S |
| 2026-02-03 | Body weight | 49.6 kg | 29463-7 | S |
| 2026-02-03 | Body mass index (BMI) [Ratio] | 21.5 kg/m2 | 39156-5 | S |
| 2026-02-03 | Systolic blood pressure | 116 mm[Hg] | 8480-6 | S |
| 2026-02-03 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 2026-02-03 | Heart rate | 78 /min | 8867-4 | S |
| 2026-02-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-02-03 | Body temperature | 36.5 Cel | 8310-5 | S |
| 2026-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-03-03 | Body height | 152 cm | 8302-2 | S |
| 2026-03-03 | Body weight | 50.2 kg | 29463-7 | S |
| 2026-03-03 | Body mass index (BMI) [Ratio] | 21.7 kg/m2 | 39156-5 | S |
| 2026-03-03 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 2026-03-03 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-03-03 | Heart rate | 76 /min | 8867-4 | S |
| 2026-03-03 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-03-03 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-03-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-04-14 | Body height | 152 cm | 8302-2 | S |
| 2026-04-14 | Body weight | 50.9 kg | 29463-7 | S |
| 2026-04-14 | Body mass index (BMI) [Ratio] | 22 kg/m2 | 39156-5 | S |
| 2026-04-14 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-04-14 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-04-14 | Heart rate | 72 /min | 8867-4 | S |
| 2026-04-14 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-04-14 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-06-16 | Body height | 152 cm | 8302-2 | S |
| 2026-06-16 | Body weight | 51.6 kg | 29463-7 | S |
| 2026-06-16 | Body mass index (BMI) [Ratio] | 22.3 kg/m2 | 39156-5 | S |
| 2026-06-16 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 2026-06-16 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 2026-06-16 | Heart rate | 70 /min | 8867-4 | S |
| 2026-06-16 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-06-16 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-07-27 | Body height | 152 cm | 8302-2 | S |
| 2026-07-27 | Body weight | 51.8 kg | 29463-7 | S |
| 2026-07-27 | Body mass index (BMI) [Ratio] | 22.4 kg/m2 | 39156-5 | S |
| 2026-07-27 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-07-27 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-07-27 | Heart rate | 84 /min | 8867-4 | S |
| 2026-07-27 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-07-27 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-07-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-10-13 | Body height | 152 cm | 8302-2 | S |
| 2026-10-13 | Body weight | 52 kg | 29463-7 | S |
| 2026-10-13 | Body mass index (BMI) [Ratio] | 22.5 kg/m2 | 39156-5 | S |
| 2026-10-13 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-10-13 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 2026-10-13 | Heart rate | 68 /min | 8867-4 | S |
| 2026-10-13 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-10-13 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-10-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: registered nurse and founding director of a disaster and war relief agency; returned four months ago from eighteen months leading field hospitals and supply convoys in a war zone; previous long deployments in her forties
- S Never smoker; one or two glasses of wine a week; no other substance use
- S Lives alone in a small house near the agency's warehouse; never married; no children
- S Works 60 to 70 hours a week since her return, answering families' letters and calls and raising funds; has taken no leave in two years
- S Supports: a few close friends from earlier relief work, colleagues at the agency, and a faith community; no firearms in the home
Functional status
- S At intake, still working but taking twice as long over letters and reports, eating little, and withdrawing from friends
- S Back at full duties on a 45-hour week by the five-month review, seeing friends weekly, and walking daily
Mental status
- S Small, upright, neatly dressed; speech soft and slow; good eye contact; cooperative and precise
- S Mood "worn out and no use to anyone"; affect constricted and tearful at times; thought process linear; no suicidal ideation, intent, or plan; no psychotic features; insight and judgment good
Structured safety assessment
This assessment is synthetic and does not convert historical behavior into a present-day fact.
Allergies and medications
Allergies
- S No known allergy
Medications
- S Sertraline 50 mg oral tablet, one tablet by mouth each morning
- S Sertraline 100 mg oral tablet, one tablet by mouth each morning
- S Ibuprofen 400 mg oral tablet, one tablet by mouth up to three times a day with food for no more than 7 days
Procedures and immunizations
Procedures
- S Advance care planning conversation, about 20 minutes
Immunizations
- S 2025-10-06: Influenza vaccine, 2025-2026 season
- S 2024-05-13: Tdap vaccine, before deployment
- S 2026-10-13: Influenza vaccine, 2026-2027 season
- S 2026-10-13: Pneumococcal conjugate vaccine PCV20
- S 2026-10-13: Recombinant zoster vaccine, dose 1 of 2
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D Spring 1852: Brief period of depression recorded in her diary while teaching (CLM-0002)
- D September 1862: Typhoid fever after several days tending the wounded at Antietam (CLM-0003)
- D December 1868: Loss of voice during a lecture from fatigue and mental prostration, then helpless through the winter; went to Europe on medical advice the next autumn (CLM-0006, CLM-0007)
- D 1872 to 1873: Nervous exhaustion with temporary loss of eyesight; confined to bed for eight months with a cough in England (CLM-0009)
- D October 1873: Breakdown with prostration of the nervous system after returning home (CLM-0010)
Family history
- D mother: Died in 1851; cause not recorded in the cited source
- D father: Died in 1862; cause not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Response (PHQ-9 down by at least 50 percent) by twelve weeks | 2026-04-14 | completed | PHQ-9 7 at twelve weeks, down 61 percent from 18 |
| Remission (PHQ-9 below 5) and continuation treatment for at least twelve months after remission | 2026-06-16 | active | Remission reached at five months (PHQ-9 4); continuation treatment under way |
| Sleep at least six hours most nights | 2026-04-14 | completed | About six and a half hours most nights by twelve weeks |
| Phased return to work at no more than 45 hours a week, with no field deployment for at least six months | 2026-06-16 | completed | Full duties at 45 hours a week from April; no deployment |
| Time with friends or her faith community at least twice a week | 2026-06-16 | completed | Weekly dinner with friends and weekly services |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Shared decision-making: combined psychotherapy and an antidepressant for a recurrent, moderately severe episode; she chose cognitive behavioral therapy and sertraline | completed | GL-MDD-2022, GL-CMID-2026 |
| Start sertraline 50 mg each morning; check tolerability and safety at two weeks; increase to 100 mg if the PHQ-9 has fallen by less than 50 percent after four to six weeks | completed | GL-MDD-2022, GL-CMID-2026 |
| Weekly cognitive behavioral therapy with the clinic psychologist, by video or in person, for about 16 sessions, including behavioral activation and insomnia components | completed | GL-MDD-2022, GL-CMID-2026 |
| Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; medicines stored safely and dispensed in 30-day supplies | completed | GL-SUICIDE-2024 |
| Psychiatry consultation to confirm the diagnosis, exclude bipolar disorder and PTSD, and advise on treatment of a recurrent episode | completed | GL-MDD-2022, GL-CMID-2026 |
| PHQ-9 at every visit and at least monthly until remission; suicide-risk review at every visit; continue sertraline for at least twelve months after remission because the episode is recurrent | completed | GL-MDD-2022, GL-CMID-2026, GL-SUICIDE-2024 |
| Burnout and work: two weeks of medical leave, then a phased return with a 45-hour cap, no field deployment for at least six months, delegation of the families' correspondence, and a peer support group for relief workers | completed | GL-MDD-2022, GL-CMID-2026 |
| Sleep and activity: fixed wake time, no work after 8 pm, a daily 30-minute walk, regular meals, and limited alcohol; prolonged bed rest or withdrawal from activity is explained as unhelpful for depression | completed | GL-MDD-2022, GL-CMID-2026 |
| Screen for bipolar disorder, PTSD, anxiety, and unhealthy alcohol use, and check thyroid, blood count, vitamin B12, and a metabolic panel for medical contributors to fatigue | completed | GL-MDD-2022, GL-CMID-2026, GL-USPSTF-DEP-2023 |
Planned encounters
- 2026-01-20 — Primary care visit for low mood, exhaustion, and poor sleep after returning from a long humanitarian deployment (ENC-001)
- 2026-02-03 — Two-week sertraline tolerability and safety check, with psychiatry consultation (ENC-002)
- 2026-03-03 — Six-week depression treatment review (ENC-003)
- 2026-04-14 — Twelve-week depression treatment review (ENC-004)
- 2026-06-16 — Five-month depression review in continuation treatment (ENC-005)
- 2026-07-27 — Same-day sick visit for low back pain after lifting (ENC-006, unscheduled)
- 2026-10-13 — Periodic adult preventive visit (ENC-007)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Focused Visit (Care-plan review)
- Progress note 06 — Sick Visit
- Progress note 07 — Preventive Visit
- Psychiatry referral
- Psychiatry consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Focused Visit (Care-plan review) (XML)
- Progress note 06 — Sick Visit (XML)
- Progress note 07 — Preventive Visit (XML)
- Psychiatry referral (XML)
- Psychiatry consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Clara Barton Chronology, 1821-1860, 1861-1869, and 1870-1912 | National Park Service, Clara Barton National Historic Site | government |
| SRC-0002 | HISTMED Master Roster v3 | The Human Record project | other |
| SRC-0003 | Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 1. Boston: Houghton Mifflin; 1922 | Project Gutenberg (eBook 67505) | biography |
| SRC-0004 | Barton WE. The Life of Clara Barton, Founder of the American Red Cross, Volume 2. Boston: Houghton Mifflin; 1922 | Project Gutenberg (eBook 67954) | biography |
| SRC-0005 | Spiegel AD. The role of gender, phrenology, discrimination and nervous prostration in Clara Barton's career. J Community Health. 1995;20(6):501-526. doi:10.1007/BF02277066 | PubMed (PMID 8568024) | scholarly |
| SRC-0006 | Henneberger M. Clara Barton's inner war. Bangor Daily News, April 7, 2012 | Bangor Daily News | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check combination treatment, sertraline titration, safety review at every visit, the burnout and return-to-work plan, and the recorded deviation. |
| provenance review | not_started | NPS chronology pages, the 1922 two-volume biography on Project Gutenberg, one PubMed abstract, and one newspaper article logged. Nervous prostration and diary depression are D; the depression interpretation is R. The Library of Congress pages could not be fetched (bot challenge). |
| safe messaging review | not_started | Safety assessment is synthetic with no current ideation; historical diary passages about wishing to die or suicide are not quoted or used; the rest cure is recorded as history, not as effective treatment. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.